Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | +0.90% | +1.66% | +13.79% |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.79% | 31.18B | |
+2.54% | 75.22B | |
+18.76% | 69.31B | |
+15.79% | 35.76B | |
+9.72% | 28.24B | |
+6.10% | 27.04B | |
+5.14% | 26.04B | |
+12.84% | 24.07B | |
+12.11% | 23.39B | |
+5.53% | 15.96B |
- Stock Market
- Equities
- XYL Stock
- News Xylem Inc.
- Xylem to Acquire Evoqua in $7.5 Billion All-Stock Transaction